Collaboration to support clinical development, regulatory, commercial and real-world evidence to accelerate the development of new indications for VYVGART.
Includes a series of investments to acquire new equipment and adapt the present ROVI drug product fill-finish facilities and production lines in Spain.
Includes a multimillion-dollar investment to expand Corning’s Valor Glass technology to enable advanced injectable drug packaging and delivery systems.
Penn’s innovation in process science combines with CBM manufacturing capability for large-scale gene therapy manufacturing capacity, testing and analytics.